142 related articles for article (PubMed ID: 38057424)
1. Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management.
Akyildiz A; Ismayilov R; Rustamova N; Tokatli M; Koc I; Akin S; Kiratli H; Barista I
Ann Hematol; 2024 Mar; 103(3):905-915. PubMed ID: 38057424
[TBL] [Abstract][Full Text] [Related]
2. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
3. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
5. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
[TBL] [Abstract][Full Text] [Related]
6. A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG).
Kalicińska E; Giza A; Zaucha JM; Giebel S; Zimowska-Curyło D; Andrasiak I; Spychałowicz W; Wojnar J; Balcerzak A; Romejko-Jarosińska J; Paszkiewicz-Kozik E; Knopińska-Posłuszny W; Rybka J; Jabłonowska P; Wróbel T
Cancer Med; 2023 Feb; 12(3):3036-3045. PubMed ID: 36161781
[TBL] [Abstract][Full Text] [Related]
7. Orbital lymphoma: diagnostic approach and treatment outcome.
Eckardt AM; Lemound J; Rana M; Gellrich NC
World J Surg Oncol; 2013 Mar; 11():73. PubMed ID: 23506357
[TBL] [Abstract][Full Text] [Related]
8. Extraocular muscle involvement in marginal zone B-cell lymphomas of the orbit.
Izambart C; Robert PY; Petellat F; Petit B; Gastaud P; Lagier J; Labrousse F; Adenis JP
Orbit; 2008; 27(5):345-9. PubMed ID: 18836931
[TBL] [Abstract][Full Text] [Related]
9. Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions.
Yoon JS; Ma KT; Kim SJ; Kook K; Lee SY
Ophthalmic Plast Reconstr Surg; 2007; 23(2):94-9. PubMed ID: 17413620
[TBL] [Abstract][Full Text] [Related]
10. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
Holm F; Mikkelsen LH; Kamper P; Rasmussen PK; Larsen TS; Sjö LD; Heegaard S
Br J Ophthalmol; 2021 Jul; 105(7):914-920. PubMed ID: 32732342
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, outcomes, and prognostic factors of orbital lymphoma in the United States.
Ahmed OM; Ma AK; Ahmed TM; Pointdujour-Lim R
Orbit; 2020 Dec; 39(6):397-402. PubMed ID: 31894706
[TBL] [Abstract][Full Text] [Related]
12. Orbital lymphoma.
Olsen TG; Heegaard S
Surv Ophthalmol; 2019; 64(1):45-66. PubMed ID: 30144455
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification.
Kwon M; Lee JS; Lee C; Yoon DH; Sa HS
Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417
[TBL] [Abstract][Full Text] [Related]
14. Orbital and ocular adnexal lymphoma: a review of epidemiology and prognostic factors in Taiwan.
Hsu CR; Chen YY; Yao M; Wei YH; Hsieh YT; Liao SL
Eye (Lond); 2021 Jul; 35(7):1946-1953. PubMed ID: 32994547
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
[TBL] [Abstract][Full Text] [Related]
16. Orbital Lymphoma-An International Multicenter Retrospective Study.
Olsen TG; Holm F; Mikkelsen LH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Sjö LD; Vemuganti GK; Thuro BA; Heegaard S
Am J Ophthalmol; 2019 Mar; 199():44-57. PubMed ID: 30419193
[TBL] [Abstract][Full Text] [Related]
17. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.
Bayraktar S; Bayraktar UD; Stefanovic A; Lossos IS
Br J Haematol; 2011 Jan; 152(1):72-80. PubMed ID: 21083656
[TBL] [Abstract][Full Text] [Related]
18. Ocular adnexal lymphomas: five case presentations and a review of the literature.
Coupland SE; Hummel M; Stein H
Surv Ophthalmol; 2002; 47(5):470-90. PubMed ID: 12431695
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of orbital lymphoma: a clinicopathological study of 26 cases.
Briscoe D; Safieh C; Ton Y; Shapiro H; Assia EI; Kidron D
Int Ophthalmol; 2018 Feb; 38(1):271-277. PubMed ID: 28364339
[TBL] [Abstract][Full Text] [Related]
20. Orbital MALT Lymphoma after Autologous Stem Cell Transplantation for Follicular Lymphoma as Relapse of Diffuse Large B-Cell Lymphoma.
Matsuo T; Tanaka T; Fujii N
J Clin Exp Hematop; 2017; 56(3):170-175. PubMed ID: 28331132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
